Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease Via Skewing T Cells Polarization Towards Treg Cells

Huihui Liu, PhD, Zhengyu Yu, MD, Bo Tang, MD, Shengchao Miao, MD, Chenchen Qin, Yuan Li, MD, Zeyin Liang, MD, Yang Zhang, Hanyun Ren, MD, Yujun Dong, MD

Blood (2020) 136 (Supplement 1): 4.

https://doi.org/10.1182/blood-2020-141877

Published: 2020

Journal Articles

Paroxysmal Nocturnal Hemoglobinuria Clones Are Infrequent in Hepatitis-Associated Aplastic Anemia at the Time of Diagnosis

Wenrui Yang, MD, Xin Zhao, MD PhD, Guangxin Peng, MD, Li Zhang, MD, Liping Jing, MD, Kang Zhou, MD, Yang Li, MD, Lei Ye, MD, Yuan Li, MD, Jianping Li, MD, Huihui Fan, MD, Lin Song, MD, Yang Yang, MD, Youzhen Xiong, MD, Fengkui Zhang, MD, Jianxiang Wang, MD

Blood (2019) 134 (Supplement_1): 5016.

https://doi.org/10.1182/blood-2019-125620

Published: 2019

Journal Articles

Decitabine Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft Versus Host Disease

Yuan Li, MD, Qing Ya Wang, MD, Ze Yin Liang, Yue Yin, Wei Liu, MD PhD, Qian Wang, Yujun Dong, MD, YuHua Sun, Wei Lin Xu, Hanyun Ren, MD PhD

Blood (2019) 134 (Supplement_1): 5647.

https://doi.org/10.1182/blood-2019-125275

Published: 2019

Journal Articles

Novel Bio-Markers Latent Membrane Protein 1 and microRNA-155 for the Prognostic Prediction of Diffuse Large B Cell Lymphoma

Xue Wu, MD, Fei Wang, MDPhD, Yuan Li, MD, Haijun ZHang, MDPhD, Ping Liu, MD, Xiyong Wang, MD, Zheng Ge, MD PhD, Chong Gao, MD, Bao-An Chen, MDPhD

Blood (2017) 130 (Supplement 1): 5571.

https://doi.org/10.1182/blood.V130.Suppl_1.5571.5571

Published: 2017

Journal Articles

RNA:m 5 c/Methyltransferases Mediate Chromatin Organization and 5-Azacytidine Response/Resistance in Leukemia

Jason Cheng, MD PhD, Li Chen, PhD MD, Yuan Li, MD, Ming Yue, PhD, Adam Cloe, MD, PhD, Jamile M. Shammo, MD FASCP, FACP, Richard A. Larson, MD, Chuan He, PhD, Michelle M. Le Beau, PhD, James W. Vardiman, MD

Blood (2017) 130 (Supplement 1): 2471.

https://doi.org/10.1182/blood.V130.Suppl_1.2471.2471

Published: 2017

Journal Articles

Wogonin As a Targeted Therapeutic Agent for EBV (+) Lymphoma Cells Involved in LMP1/NF-κB/Mir-155/PU.1 Pathway

Xue Wu, MD, Ping Liu, MD, Haijun ZHang, MDPhD, Yuan Li, MD, Jumah Masoud Mohammad Salmani, MDPhD, Fei Wang, MDPhD, Ke Yang, MD, Rong Fu, PhD, Baoan Chen, MDPhD, Zhewei Chen

Blood (2017) 130 (Supplement 1): 5204.

https://doi.org/10.1182/blood.V130.Suppl_1.5204.5204

Published: 2017

Journal Articles

Identification of Specific Hnrnps As Novel Therapeutic Targets and Responsive Indicators of KPT330 (selinexor) in Leukemia

Adam Cloe, MD PhD, Li Chen, MD PhD, Yuan Li, MD, Hongtao Liu, MD PhD, Jason X. Cheng, MD PhD

Blood (2016) 128 (22): 1657.

https://doi.org/10.1182/blood.V128.22.1657.1657

Published: 2016

Journal Articles

Bromodomain and Extra-Terminal Motif Proteins (BETs) Mediate 5-Azacitidine Resistance in Myeloid Leukemia through Recruitment of an Active RNA Polymerase II Complex

Li Chen, MD PhD, Yuan Li, MD, Ming Yue, PhD, Adam Cloe, MD PhD, Michelle M. Le Beau, PhD, Chuan He, PhD, Richard A. Larson, MD, James W. Vardiman, MD, Jason X. Cheng, MD PhD

Blood (2016) 128 (22): 746.

https://doi.org/10.1182/blood.V128.22.746.746

Published: 2016

Journal Articles

Epigenetic Modifying Drugs Inhibit MDS/AML Cell Growth through Selective Disruption of the Interactions Between Lineage-Determining Transcription Factors and DNA/Histone Modifiers

Yuan Li, MD, Ming Yue, PhD, John Anastasi, MD, Jeffery Q Shen, PhD, Yali Dou, PhD, Richard A. Larson, MD, James W. Vardiman, MD, Jason X. Cheng, MDPhD

Blood (2015) 126 (23): 3853.

https://doi.org/10.1182/blood.V126.23.3853.3853

Published: 2015

NARROW

LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease Via Skewing T Cells Polarization Towards Treg Cells

Paroxysmal Nocturnal Hemoglobinuria Clones Are Infrequent in Hepatitis-Associated Aplastic Anemia at the Time of Diagnosis

Decitabine Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft Versus Host Disease

Novel Bio-Markers Latent Membrane Protein 1 and microRNA-155 for the Prognostic Prediction of Diffuse Large B Cell Lymphoma

RNA:m 5 c/Methyltransferases Mediate Chromatin Organization and 5-Azacytidine Response/Resistance in Leukemia

Wogonin As a Targeted Therapeutic Agent for EBV (+) Lymphoma Cells Involved in LMP1/NF-κB/Mir-155/PU.1 Pathway

Identification of Specific Hnrnps As Novel Therapeutic Targets and Responsive Indicators of KPT330 (selinexor) in Leukemia

Bromodomain and Extra-Terminal Motif Proteins (BETs) Mediate 5-Azacitidine Resistance in Myeloid Leukemia through Recruitment of an Active RNA Polymerase II Complex

Epigenetic Modifying Drugs Inhibit MDS/AML Cell Growth through Selective Disruption of the Interactions Between Lineage-Determining Transcription Factors and DNA/Histone Modifiers

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only